Switch to: References

Add citations

You must login to add citations.
  1. Public Value Mapping of Equity in Emerging Nanomedicine.Catherine P. Slade - 2011 - Minerva 49 (1):71-86.
    Public values failure occurs when the market and the public sector fail to provide goods and services required to achieve the core values of society such as equity (Bozeman 2007). That public policy for emerging health technologies should address intrinsic societal values such as equity is not a novel concept. However, the ways that the public values discourse of stakeholders is structured is less clear and rarely studied through the lens of public interests. This is especially true in the health (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Regulating Nanomedicine—the Smallest of Our Concerns?Roger Brownsword - 2008 - NanoEthics 2 (1):73-86.
    This paper, guided by the UNESCO Universal Declaration on Bioethics and Human Rights, assumes that regulators should aim to support the development of nanomedicine while, at the same time, putting in place whatever limits or safeguards are indicated by ethical considerations. Relative to this regulatory objective, it is argued that, notwithstanding the importance of precaution (characteristically, concerning health, safety, and the environment), ethical reflection needs to go both broader and deeper. It is suggested that, by attending to the basic matrix (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations